Allecra therapeutics and Acino sign exclusive license and supply agreement for Exblifep( cefepime/enmetazobactum) to commercialize in South africa and member states of Gulf cooperation countries.
Allecra will supply the finished product and Acino will be involved in the registration process of Exblifep in the above countries( most likely marketing too)
we may expect few more such agreements in future:
| Subscribe To Our Free Newsletter |
